Food allergy management is shifting from passive strategies — such as avoidance, carrying epinephrine and hope — to proactive ...

Desensitisation is possible. A family of treatments known as immunotherapies work by repeatedly exposing the body to tiny and gradually increasing amounts of allergen. For common allergens, such as ...

The omalizumab trial from 2024 included a small number of adults, and in April an adult-only trial showed that standard oral immunotherapy, done carefully over months, could build patients up to a ...

In managing antihistamine-refractory chronic urticaria, omalizumab and remibrutinib stand out among the most effective treatments across multiple patient-important outcomes, followed by dupilumab ...

HealthDay News — Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study published online July 15 in ...

A massive global study has ranked the best and safest treatments for chronic hives when antihistamines fall short. The findings provide a clear treatment roadmap for both patients and clinicians ...

A third drug - omalizumab - also seems to improve the symptoms of people who have severe chronic rhinosinusitis with nasal polyps. What was studied in the review? We looked for trials where patients ...